TY - JOUR
T1 - Hypotension during Septic Shock Does Not Correlate with Plasma Levels of Nitric Oxide Metabolites in the Conscious Rat
AU - Klemm, Klaus
AU - Mercer, David W.
AU - Mailman, David
AU - Moody, Frank G.
N1 - Funding Information:
From the Departmento f Surgery (K.K., D.W.M., and EGM.), University ofTeuas-Houston Medical School, and the Department of Biology (D.M.), University of Houston, Houston, T&x. Supported in part by Deutsche Forschungsgemeinschaft grant KL 93 Ill-2 (ILK) and the Trauma Research Center, Houston, sponsored by National Institutes of Health grant GM 38529 (F.G.M.). Presented at the Thirty-Seventh Annual Meeting of The Society for Surgery of the Alimentary Tract, San Francisco, Calif., May 19-22,1996. Reprint requests: David W. Mercer, M.D., University of Texas-Houston Medical School, Department of Surgery, 643 1 Fannin, MSB 4.286, Houston, TX 77030.
PY - 1997
Y1 - 1997
N2 - Hypotension following administration of lipopolysaccharide may be due to excessive production of the potent vasodilator nitric oxide brought about by induction of nitric oxide synthase. The purpose of this study was to determine in conscious, fasted rats what role nitric oxide played in lipopolysaccharide-induced hypotension. When examined by Western immunoblot analysis, inducible nitric oxide synthase immunoreactivity was detected in the aorta at 3 hours and increased over time following administration of intraperitoneal lipopolysaccharide (20 mg/kg). When compared with saline-treated control rats, significant hypotension was observed at 2, 4, and 6 hours following lipopolysaccharide treatment. Blood pressure at 2 hours did not differ significantly from that at 6 hours. Using the Griess reaction to quantify plasma levels of nitrates and nitrites as an index of systemic nitric oxide production, an augmentation in the formation of these nitric oxide metabolites was demonstrated at 4 and 6 hours but not at 2 hours. Subcutaneous administration of the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (5 mg/kg) prevented lipopolysaccharide-induced hypotension, an effect reversed by subcutaneous L-arginine but not D-arginine (350 mg/kg). However, nitric oxide synthase inhibition did not attenuate the ability of lipopolysaccharide to increase plasma nitrate/nitrite levels. These data indicate that lipopolysaccharide-induced production of nitric oxide metabolites does not correlate with lipopolysaccharide-induced hypotension.
AB - Hypotension following administration of lipopolysaccharide may be due to excessive production of the potent vasodilator nitric oxide brought about by induction of nitric oxide synthase. The purpose of this study was to determine in conscious, fasted rats what role nitric oxide played in lipopolysaccharide-induced hypotension. When examined by Western immunoblot analysis, inducible nitric oxide synthase immunoreactivity was detected in the aorta at 3 hours and increased over time following administration of intraperitoneal lipopolysaccharide (20 mg/kg). When compared with saline-treated control rats, significant hypotension was observed at 2, 4, and 6 hours following lipopolysaccharide treatment. Blood pressure at 2 hours did not differ significantly from that at 6 hours. Using the Griess reaction to quantify plasma levels of nitrates and nitrites as an index of systemic nitric oxide production, an augmentation in the formation of these nitric oxide metabolites was demonstrated at 4 and 6 hours but not at 2 hours. Subcutaneous administration of the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (5 mg/kg) prevented lipopolysaccharide-induced hypotension, an effect reversed by subcutaneous L-arginine but not D-arginine (350 mg/kg). However, nitric oxide synthase inhibition did not attenuate the ability of lipopolysaccharide to increase plasma nitrate/nitrite levels. These data indicate that lipopolysaccharide-induced production of nitric oxide metabolites does not correlate with lipopolysaccharide-induced hypotension.
UR - http://www.scopus.com/inward/record.url?scp=0001134640&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0001134640&partnerID=8YFLogxK
U2 - 10.1016/S1091-255X(97)80056-X
DO - 10.1016/S1091-255X(97)80056-X
M3 - Article
C2 - 9834369
AN - SCOPUS:0001134640
VL - 1
SP - 347
EP - 356
JO - Journal of Gastrointestinal Surgery
JF - Journal of Gastrointestinal Surgery
SN - 1091-255X
IS - 4
ER -